BioWorld Asia

Jan. 3, 2007

European Drug Agency Predicts Another Bumper Year in 2007

BRUSSELS, Belgium - The London-based European Medicines Agency is expecting a high level of activity in 2007, and much of the work is likely to come from evaluation of new biotechnology medicine applications. (BioWorld International) Read More

On The Brink of Bankruptcy, GeneMedix Finds A Rescuer

New Breast Cancer Gene Moves Focus To Role of DNA Repair

Neuropharma Raises $41.7M For Alzheimer's Development

Cellectis Files IPO Prospectus On The Paris Stock Exchange

Protherics seeking $74.4 M And Expanded Product Line

SkyePharma Gets New Loan For Flutiform Development

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...